Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?

Danielle K DePaloRachel M LeeAlexandra G Lopez-AguiarAdriana C GamboaFlavio RochaGeorge PoultsidesMary DillhoffRyan C FieldsKamran IdreesHari NathanDaniel AbbottShishir K MaithelMaria C Russellnull null

Published in: Journal of surgical oncology (2019)

Black patients with GEP-NETs had more adverse characteristics and higher LN positivity. Despite this, Black patients have improved RFS. This may be attributed to the epidemiologic differences in the primary site of GEP-NETs and variable prognostic value of LN-positive disease.

Keyphrases

neuroendocrine tumors
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
patient reported outcomes
african american
patient reported